MSB 2.58% 94.5¢ mesoblast limited

Ann: Novartis and Mesoblast Remestemcel-L Collaboration, page-142

  1. 11,486 Posts.
    lightbulb Created with Sketch. 728
    Novartis is funding NON COVID ARDS so is a separtae and new trial.

    Note Sector has not said a word about the likely cost of this being far more than 50 million - the one who refuses to read the truth is on display.


 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.5¢
Change
-0.025(2.58%)
Mkt cap ! $1.078B
Open High Low Value Volume
98.0¢ 98.5¢ 94.0¢ $2.482M 2.602M

Buyers (Bids)

No. Vol. Price($)
6 71720 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 10463 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.